Posted by Michael Wonder on 29 Sep 2021
Novian Health gains FDA breakthrough designation for Novilase breast therapy
28 September 2021 - Novian Health has been granted breakthrough device designation from the U.S. FDA for its Novilase Interstitial Laser System and its proposed indication for the focal destruction of malignant breast tumours in adult women who seek a breast conserving procedure.
Novilase is a minimally invasive procedure that uses laser ablation to destroy tumours as an alternative to surgery.
